TW0006469000
TW0006469000
GREAT TREE PHARMACY CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 10.56B EUR | 11.91B EUR | 12.91B EUR | 14.85B EUR |
Enterprise Value | 14B EUR | 17.68B EUR | 18.34B EUR | 20.15B EUR |
Valuation Multiples | ||||
Trailing P/E | 21.08x | 23.1x | 22.81x | 33.71x |
Forward P/E | 17.08x | -- | -- | -- |
Price to Sales | 0.56x | 0.63x | 0.68x | 1.04x |
Price to Book | 2.72x | 3.25x | 3.62x | 3.79x |
EV/Revenue | 0.74x | 0.93x | 0.96x | 1.42x |
EV/EBITDA | 17.83x | 11.11x | 10.9x | 15.7x |
Price to FCF (P/FCF) | 10x | 20.51x | 17.11x | 15.61x |
EV/FCF | 13.25x | 30.43x | 24.31x | 21.18x |
FCF Yield | 10% | 4.88% | 5.85% | 6.41% |